S. Tokuyama et al., NALOXONE-PRECIPITATED CHANGES IN BIOGENIC-AMINES AND THEIR METABOLITES IN VARIOUS BRAIN-REGIONS OF BUTORPHANOL-DEPENDENT RATS, Pharmacology, biochemistry and behavior, 54(2), 1996, pp. 461-468
Influence of a naloxone (an opioid receptor antagonist) challenge (5 m
g/kg, IP) on levels of biogenic amines and their metabolites in variou
s brain regions of rats infused continuously with butorphanol (a mu/de
lta/kappa mixed opioid receptor agonist; 26 nmol/mu 1/h) or morphine (
a mu-opioic receptor agonist; 26 nmol/mu 1/h) was investigated using h
igh-performance liquid chromatography with electrochemical detection (
HPLC-ED). Naloxone precipitated a withdrawal syndrome and decreased th
e levels of: dopamine (DA) in the cortex and striatum, 3,4-dihydroxyph
enylacetic acid (DOPAC) in the striatum, homovanilic acid (HVA) in the
striatum, limbic, midbrain, and pons/medulla regions in butorphanol-d
ependent rats. However, the levels of norepinephrine (NE): serotonin (
5-hydroxytryptamine; 5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) in
the regions studied were not affected by naloxone-precipitated withdr
awal. In addition, naloxone increased the HVA/DA ratio in the cortex,
while this ratio was reduced in the limbic, midbrain, and pons/medulla
. The reduction of 5-HIAA/5-HT ratio was also detected in the limbic a
rea. In the animals rendered dependent on morphine, the results obtain
ed were similar to those of butorphanol-dependent rats except for chan
ges of 5-HIAA levels in some brain regions. These results suggest that
an alteration of dopaminergic neuron activity following a reduction o
f DA and its metabolites in specific brain regions (e.g., striatum, li
mbic, midbrain, and pons/medulla) play an important role in the expres
sion of the opioid withdrawal syndrome.